Aquatic Capital Management LLC Atreca, Inc. Transaction History

Aquatic Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.59 - $2.74 $159 - $274	100 New	100 $0
Q2 2022 Aug 15, 2022	SELL	$1.56 - $3.25 $468 - $975	-300 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.61 - $5.2 $1,932 - $6,240	-1,200 Reduced 80.0%	300 $1,000
Q4 2021 Feb 14, 2022	BUY	$2.87 - $6.29 $4,305 - $9,435	1,500 New	1,500 $5,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.